LCTX Competitors & Alternatives
Compare Lineage Cell Therapeutics Inc with similar stocks in the same industry
Biotechnology
LCTX
Main Stock$1.28
Tradestie Score
54
Market Cap
$385.92M
Revenue Growth
0.1%
Analyst Upside
+331.4%
Top Competitors
225 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CGEM
Cullinan Therapeutics, Inc. Common Stock
|
$13.74
|
$354.45M | - | 49 | Compare |
|
LBRX
LB Pharmaceuticals Inc Common Stock
|
$28.89
|
$353.70M | - | 56 | Compare |
|
PROK
ProKidney Corp. Class A Ordinary Shares
|
$1.67
|
$350.98M | - | 51 | Compare |
|
ALT
Altimmune, Inc. Common Stock
|
$2.66
|
$341.56M | - | 55 | Compare |
|
ANNX
Annexon, Inc. Common Stock
|
$4.64
|
$332.96M | - | 53 | Compare |
|
REPL
Replimune Group, Inc.
|
$8.98
|
$328.62M | - | 60 | Compare |
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$8.65
|
$304.12M | - | 59 | Compare |
|
JBIO
Jade Biosciences, Inc. Common Stock
|
$15.85
|
$297.23M | - | 50 | Compare |
|
TECX
Tectonic Therapeutic, Inc. Common Stock
|
$29.97
|
$293.03M | - | 56 | Compare |
|
OMER
Omeros Corporation
|
$9.20
|
$281.75M | 8.9 | 48 | Compare |
More LCTX Analysis
Data updated: Jun 15, 2026 | Industry: Biotechnology (SIC 2836)
225 stocks in this industry